Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Soluble receptor for advanced glycation end products (SRAGE): A novel biomarker and potential inhibitor of atherosclerosis. Observations from the Dallas Heart Study

Soluble receptor for advanced glycation end products (SRAGE): A novel biomarker and potential inhibitor of atherosclerosis. Observations from the Dallas Heart Study. JACC. 2008; 51(10):A288.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.